Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …

Background: Patients with diabetes mellitus need information about the effectiveness of
innovations in insulin delivery and glucose monitoring. Purpose: To review how intensive …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Insulin Pump Therapy : American Journal of Therapeutics Insulin Pump Therapy : American
Journal of Therapeutics Log in or Register Subscribe to journalSubscribe Get new issue …

In the 1990s, average annual new illness rates (incidence rates) were reported between
12.9 (95% confidence interval 12.4–13.4) and 14.2 (95% confidence interval 12.9–15.5) per …

Thirty years after its introduction, the use of continuous subcutaneous insulin infusion (CSII)
keeps increasing, especially among children and adolescents. The technique, when used …

BACKGROUND: Diabetes mellitus is defined as a group of metabolic diseases
characterized by hyperglycemia, which when untreated can lead to long-term complications …

With the advent of continuous subcutaneous insulin infusion therapy and the findings of the
Diabetes Control and Complications Trial, the management of type 1 diabetes has changed …

Background Although insulin pump therapy is an important treatment modality for patients
with type 1 diabetes, rates of pump use appear to vary broadly internationally. This study …

Health‐care technologies have brought many benefits to the medical profession and to
patients. The introduction of the continuous subcutaneous insulin infusion (CSII) pump and …